title: Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
abstract: At present, brain tumor is among the most challenging diseases to treat and the therapy is limited by the lack of effective methods to deliver anticancer agents across the blood-brain barrier (BBB). BBB is a selective barrier that separates the circulating blood from the brain extracellular fluid. In its neuroprotective function, BBB prevents the entry of toxins, as well as most of anticancer agents and is the main impediment for brain targeted drug delivery approaches. Nanotechnology-based delivery systems provide an attractive strategy to cross the BBB and reach the central nervous system (CNS). The incorporation of anticancer agents in various nanovehicles facilitates their delivery across the BBB. Moreover, a more powerful tool in brain tumor therapy has relied surface modifications of nanovehicles with specific ligands that can promote their passage through the BBB and favor the accumulation of the drug in CNS tumors. This review describes the physiological and anatomical features of the brain tumor and the BBB, and summarizes the recent advanced approaches to deliver anticancer drugs into brain tumor using nanobiotechnology-based drug carrier systems. The role of specific ligands in the design of functionalized nanovehicles for targeted delivery to brain tumor is reviewed. The current trends and future approaches in the CNS delivery of therapeutic molecules to tumors are also discussed.
authors.affiliation: Division of Pharmaceutical Sciences, University of Missouri Kansas City, Kansas City, MO, 64108, USA.
authors.forename: Jianing
authors.initials: J
authors.lastname: Meng
authors.affiliation: Division of Pharmaceutical Sciences, University of Missouri Kansas City, Kansas City, MO, 64108, USA. vahw2@mail.umkc.edu.
authors.forename: Vivek
authors.initials: V
authors.lastname: Agrahari
authors.affiliation: Hough Ear Institute, Oklahoma City, OK, 73112, USA. iyoum@houghear.org.
authors.forename: Ibrahima
authors.initials: I
authors.lastname: Youm
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000378:metabolism; D001709:Biotechnology / Q000379:methods* / Q000639:trends; D001812:Blood-Brain Barrier / Q000187:drug effects / Q000378:metabolism; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D016503:Drug Delivery Systems / Q000379:methods* / Q000639:trends; D006801:Humans; D036103:Nanotechnology / Q000379:methods* / Q000639:trends
chemical_list: D000970:Antineoplastic Agents
keywords: Blood-brain barrier; Blood-brain tumor barrier; Brain tumor; CNS; Drug delivery; Drug transport; Ligand targeting; Nanocarrier; Nanoformulation